Sabby Management’s Synergy Pharmaceuticals, Inc. - Warrants SGYPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-5,382
| Closed | -$59K | – | 150 |
|
|
2018
Q4 | $59K | Hold |
5,382
| – | – | 0.01% | 94 |
|
|
2018
Q3 | $915K | Buy |
5,382
+128
| +2% | +$21.8K | 0.12% | 58 |
|
|
2018
Q2 | $914K | Buy |
5,254
+300
| +6% | +$52.2K | 0.14% | 62 |
|
|
2018
Q1 | $907K | Buy |
4,954
+711
| +17% | +$130K | 0.11% | 70 |
|
|
2017
Q4 | $946K | Buy |
+4,243
| New | +$946K | 0.09% | 74 |
|
|
2017
Q1 | – | Sell |
-7,536
| Closed | -$4.59M | – | 367 |
|
|
2016
Q4 | $4.59M | Sell |
7,536
-376
| -5% | -$134 | 0.27% | 55 |
|
|
2016
Q3 | $4.36M | Buy |
+7,912
| New | +$4.78K | 0.16% | 80 |
|
|
2016
Q2 | – | Sell |
-9,727
| Closed | -$2.69M | – | 373 |
|
|
2016
Q1 | $2.69M | Buy |
9,727
+6,942
| +249% | +$6.66K | 0.13% | 79 |
|
|
2015
Q4 | $1.58M | Hold |
2,785
| – | – | 0.09% | 147 |
|
|
2015
Q3 | $1.48M | Buy |
+2,785
| New | +$9.81K | 0.06% | 196 |
|
|
2013
Q3 | – | Sell |
-331,486
| Closed | -$610K | – | 250 |
|
|
2013
Q2 | $610K | Buy |
+331,486
| New | +$775K | 0.04% | 138 |
|
Sabby Management's SGYPW Position: Q4 2016 in Review
Sabby Management sold out of Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) in Q4 2016, closing a stake of 348,743 shares — an estimated $124K sold.
Sabby Management first reported a position in SGYPW in Q4 2013 and held it in 10 quarters. The position peaked at $1.87M in Q1 2015. 0 funds tracked by Wall St. Rank hold SGYPW as of Q4 2016.
- Sabby Management reported no remaining Synergy Pharmaceuticals, Inc. - Warrants position as of Q4 2016 after selling out during the quarter.
- Sabby Management sold 348,743 Synergy Pharmaceuticals, Inc. - Warrants shares in Q4 2016, an estimated $124K.
- Sabby Management first reported a position in Synergy Pharmaceuticals, Inc. - Warrants in Q4 2013 and held it in 10 quarters.
- Sabby Management's Synergy Pharmaceuticals, Inc. - Warrants position peaked at $1.87M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc. - Warrants as of Q4 2016.
Based on Sabby Management's 13F filing for Q4 2016, filed 14 Feb 2017.